Bioinformatic screen with clinical validation for the identification of novel stool based mRNA biomarkers for the detection of colorectal lesions including advanced adenoma
Open Access
- 11 August 2025
- journal article
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 29397
Abstract
Messenger RNA (mRNA) stool based biomarkers represent a promising approach for the diagnosis of colorectal cancer (CRC) and advanced adenoma (AA). But it is unclear which mRNA biomarkers have the most clinical utility. This study aims to partially fill this gap by performing an analysis which first ranks genes based on their expression profile in publicly available RNA-seq tissue datasets. Each gene was ranked based on observed differential expression across the majority of tumors as well as the level of expression in tumor tissue. Those genes with strong differential expression across the majority of tumors that were also highly expressed would have a higher ranking. The top 20 genes as ranked in the bioinformatic analysis of tumor and normal colon tissue gene expression were then tested on 114 clinical stool samples (CRC N = 33, AA N = 28, Controls N = 53). Fourteen of the genes had significant differential expression in the stool of CRC patients compared to controls (false discovery rate or FDR < 0.05). The Pearson correlation coefficient between tissue and stool expression was 0.57 (p-value = 0.007). The combined performance of the 20 genes in clinical stool samples had an area under the receiver operator curve (AUC) of 0.94 for CRC detection (sensitivity 75.5%, specificity 95%) and an AUC of 0.83 (sensitivity 55.8%, specificity 92.6%) for AA detection. The ability to use existing public transcriptomic datasets to identify promising candidate genes can substantially reduce the cost and effort required to screen for clinically useful mRNA biomarkers.Keywords
All Related Versions
Funding Information
- El Capitan Biosciences
This publication has 31 references indexed in Scilit:
- Population Screening for Colorectal Cancer Means Getting FIT: The Past, Present, and Future of Colorectal Cancer Screening Using the Fecal Immunochemical Test for Hemoglobin (FIT)Gut and Liver, 2014
- Evading apoptosis in cancerTrends in Cell Biology, 2013
- The Cancer Genome Atlas Pan-Cancer analysis projectNature Genetics, 2013
- The biology of cancer testis antigens: Putative function, regulation and therapeutic potentialMolecular Oncology, 2011
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression dataBioinformatics, 2009
- Expression profiling of fecal colonocytes for RNA-based screening of colorectal cancer.International Journal of Oncology, 2007
- Patient preferences for colorectal cancer screening: how does stool DNA testing fare?2007
- Incidence and patterns of recurrence after resection for cure of colonic cancer in a well defined populationBritish Journal of Surgery, 2006
- Cancer/testis antigens: an expanding family of targets for cancer immunotherapyImmunological Reviews, 2002
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001